Updated: FDA Temporarily Removes List Of Hospitals, Providers That Received Products From Mass. Compounder
Just hours after posting it Monday, the Food and Drug Administration removed from its website a list of hospitals and doctors that had received products from the compounding pharmacy now at the center of the fungal meningitis outbreak, saying data may be incorrect.
The agency said it is working to correct the list and will repost once it is completed. Data had been supplied to the agency by the pharmacy, the New England Compounding Center in Massachusetts.
Read the full story:
Source: Kaiser Health News
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025
- Modest Reductions in PrEP Coverage Result in Avoidable HIV Infections
September 17th 2025